Wall Street Bullish on Dividend Stocks Eli Lilly and ConocoPhillips for Potential 20%+ Gains

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-09-05 09:48:02

BTCCSquare news:

Analysts are projecting significant upside for two S&P 500 dividend payers despite modest yields. Eli Lilly (LLY) carries a 29% price target upside after its recent pullback, while ConocoPhillips (COP) shows 22% potential appreciation.

Lilly's stock decline followed disappointing Phase II results for oral weight-loss drug orforglipron, which showed 12.4% weight reduction versus 20.9% for injectable Zepbound. The market appears to be overlooking the company's broader pipeline and dominant position in metabolic therapeutics.

Energy giant ConocoPhillips represents a contrarian play as oil prices stabilize. Its disciplined capital allocation and shale assets position it to outperform peers during commodity price fluctuations.

By:

Log in to Reply

Hedera HBAR Dips to $0.22 Amid Technical Sell-Off, But Institutional Catalysts Loom

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.